Modelling and analysis of an HIV model with control strategies and cost-effectiveness

被引:3
|
作者
Chazuka, Zviiteyi [1 ]
Madubueze, Chinwendu E. [2 ]
Mathebula, Dephney [1 ]
机构
[1] Univ South Africa, Coll Econ & Management Sci, Dept Decis Sci, Preller St, Pretoria, South Africa
[2] Joseph Sarwuan Tarka Univ, Dept Math, Makurdi, Nigeria
来源
RESULTS IN CONTROL AND OPTIMIZATION | 2024年 / 14卷
关键词
Pre-exposure prophylaxis; Adherence; Optimal control; Pontryagin's maximum principle; Cost-effectiveness; DISEASE;
D O I
10.1016/j.rico.2023.100355
中图分类号
O29 [应用数学];
学科分类号
070104 ;
摘要
The Human Immunodeficiency Virus (HIV) remains a significant public health concern, despite global efforts to reduce new infections and increase access to antiretroviral treatment. While pre-exposure prophylaxis (PrEP) has shown promise in reducing new infections, its overall effectiveness is hindered by challenges in adherence. In this paper, a novel model was proposed. The basic properties of the model were established and the reproduction number for the model without control was computed. We conducted a sensitivity analysis to highlight the need for optimal control analysis and hence proposed an optimal control model that incorporates PrEP, condom use, and antiretroviral treatment to capture the dynamics of HIV transmission. The existence of the optimal control was mathematically proven and Pontryagin's maximum principle was employed to establish the necessary optimal control conditions. Utilizing demographic and epidemiological parameters specific to South Africa, we conducted numerical simulations. The results demonstrate the community-level benefits of implementing a combination of control measures for HIV reduction. Additionally, a cost-effectiveness analysis was performed to determine the most effective and economically viable control strategies. We anticipate that the findings from this analysis will provide valuable insights for policymakers in designing effective HIV control programmes.
引用
收藏
页数:22
相关论文
共 50 条
  • [31] Modelling the cost-effectiveness of wallaby control in New Zealand
    Choquenot, D
    Warburton, B
    NINETEENTH VERTEBRATE PEST CONFERENCE, PROCEEDINGS, 2000, : 169 - 174
  • [32] Different approaches to modelling the cost-effectiveness of schistosomiasis control
    Guyatt, H
    MEMORIAS DO INSTITUTO OSWALDO CRUZ, 1998, 93 : 75 - 84
  • [33] Cost-effectiveness of safer reproduction strategies to prevent HIV in Zimbabwe
    Hughes, Carolyn Smith
    Murombedzi, Caroline
    Chirenda, Thandiwe
    Chareka, Gift
    Mhlanga, Felix
    Mateveke, Bismark
    Gitome, Serah
    Makurumure, Tinei
    Matubu, Allen
    Mgodi, Nyaradzo
    Chirenje, Zvavahera
    Kahn, James G.
    Brown, Joelle
    LANCET GLOBAL HEALTH, 2018, 6 : S14 - S14
  • [34] Cost-effectiveness of different intervention strategies of HIV in Zhejiang, China
    Wu, Chensi
    Xu, Xiaolan
    Peng, Chunting
    Dong, Yin
    Lou, Zhuoqi
    Pan, Liya
    Chen, Lin
    Zeng, Yifan
    Ruan, Bing
    AIDS, 2024, 38 (13) : 1850 - 1860
  • [35] Modelling financial crime population dynamics: optimal control and cost-effectiveness analysis
    Akanni J.O.
    Akinpelu F.O.
    Olaniyi S.
    Oladipo A.T.
    Ogunsola A.W.
    Olaniyi, S. (solaniyi@lautech.edu.ng), 1600, Springer Science and Business Media Deutschland GmbH (08): : 531 - 544
  • [36] Optimal isolation control strategies and cost-effectiveness analysis of a two-strain avian influenza model
    Agusto, F. B.
    BIOSYSTEMS, 2013, 113 (03) : 155 - 164
  • [37] Cost-Effectiveness of Various Tuberculosis Control Strategies in Thailand
    Hunchangsith, Pojjana
    Barendregt, Jan J.
    Vos, Theo
    Bertram, Melanie
    VALUE IN HEALTH, 2012, 15 (01) : S50 - S55
  • [38] The cost-effectiveness of HIV control: Getting the priorities right
    Meyer-Rath, Gesine
    SOUTHERN AFRICAN JOURNAL OF HIV MEDICINE, 2007, (27) : 15 - 16
  • [39] Cost-effectiveness of dual maternal HIV and syphilis testing strategies in high and low HIV prevalence countries: a modelling study
    Rodriguez, Patricia J.
    Roberts, D. Allen
    Meisner, Julianne
    Sharma, Monisha
    Owiredu, Morkor Newman
    Gomez, Bertha
    Mello, Maeve B.
    Bobrik, Alexey
    Vodianyk, Arkadii
    Storey, Andrew
    Githuka, George
    Chidarikire, Thato
    Barnabas, Ruanne
    Barr-Dichiara, Magdalena
    Jamil, Muhammad S.
    Baggaley, Rachel
    Johnson, Cheryl
    Taylor, Melanie M.
    Drake, Alison L.
    LANCET GLOBAL HEALTH, 2021, 9 (01): : E61 - E71
  • [40] A Cost-Effectiveness Analysis of Alternative HIV Retesting Strategies in Sub-Saharan Africa
    Waters, Richard C.
    Ostermann, Jan
    Reeves, Travis D.
    Masnick, Max F.
    Thielman, Nathan M.
    Bartlett, John A.
    Crump, John A.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2011, 56 (05) : 443 - 452